Dopamine/serotonin receptor ligands.: Part 17:: A cross-target SAR approach:: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors

被引：8
作者：
Enzensperger, Christoph [1 ]
Goernemann, Tilo [2 ]
Pertz, Heinz H. [2 ]
Lehmann, Jochen [1 ]
机构：
[1] Univ Jena, Inst Pharm, Lehrstuhl Pharmazeut Med Chem, D-07743 Jena, Germany
[2] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 13期
关键词：
dopamine; serotonin; receptor ligand; azecine; cross-target SAR; protein-ligand interaction;
D O I：
10.1016/j.bmcl.2008.04.081
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Dibenzo- and benzindolo-azecines represent a novel class of high-affinity dopamine receptor antagonists. To further characterize these drugs as potential neuroleptics, we selected a set of azecine derivatives and ring expanded homologues and we measured their antagonist activity at the 5-HT(2A) receptor in the porcine coronary artery. SARs found for the 5-HT(2A) receptor resemble those for the D(1) but not the D(2) receptor. The protein-ligand interactions were discussed with respect to the different binding pockets. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3809 / 3813
页数：5
相关论文
共 22 条
  • [1] NNC-112, NNC-687 AND NNC-756, NEW SELECTIVE AND HIGHLY POTENT DOPAMINE D1 RECEPTOR ANTAGONISTS
    ANDERSEN, PH
    GRONVALD, FC
    HOHLWEG, R
    HANSEN, LB
    GUDDAL, E
    BRAESTRUP, C
    NIELSEN, EB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (01) : 45 - 52
  • [2] CUSHING DJ, 1993, J PHARMACOL EXP THER, V264, P193
  • [3] El-Subbagh H, 2002, ARCH PHARM, V335, P443, DOI 10.1002/1521-4184(200212)335:9<443::AID-ARDP443>3.0.CO
  • [4] 2-U
  • [5] Dopamine/Serotonin receptor ligands.: 16.: expanding dibenz[d,g]azecines to 11- and 12-membered homologues.: Interaction with dopamine D1-D5 receptors
    Enzensperger, Christoph
    Mueller, Franziska K. U.
    Schmalwasser, Bdrbel
    Wiecha, Petra
    Traber, Heidi
    Lehmann, Jochen
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4528 - 4533
  • [6] Dopamine/serotonin receptor ligands.: Part 15:: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists
    Enzensperger, Christoph
    Kilian, Susann
    Ackermann, Marit
    Koch, Anne
    Kelch, Kristin
    Lehmann, Jochen
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1399 - 1402
  • [7] Dopamine/serotonin receptor ligands.: 13:: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D1-D5 receptors
    Enzensperger, Christoph
    Lehmann, Jochen
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6408 - 6411
  • [8] Hamacher Alexandra, 2006, BMC Pharmacology, V6, P11, DOI 10.1186/1471-2210-6-11
  • [9] Dopamine/serotonin receptor ligands.: 10:: SAR studies on azecine-type dopamine receptor Ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist
    Hoefgen, B
    Decker, M
    Mohr, P
    Schramm, AM
    Rostom, SAF
    El-Subbagh, H
    Schweikert, PM
    Rudolf, DR
    Kassack, MU
    Lehmann, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) : 760 - 769
  • [10] Can we rationally design promiscuous drugs?
    Hopkins, AL
    Mason, JS
    Overington, JP
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2006, 16 (01) : 127 - 136
123